Germany

The agreement gives Apollo-managed funds and affiliates a non-controlling interest in a newly created entity that will hold Bayer’s LARC portfolio.

Unlike conventional sequencing technologies, Axelios 1 uses SBX chemistry to convert DNA or RNA molecules into enlarged surrogate polymers known as Xpandomers.

The collaboration integrates Cercare Medical Neurosuite (CMN), a vendor-neutral imaging platform that provides automated perfusion analysis across CT, MRI, and Cone-Beam CT, with Siemens Healthineers’ Syngo DynaCT Multiphase system.

The solution integrates Syngo.CT Coronary Cockpit on the Syngo.via platform with Syngo PCI Connect running on Artis angiography systems.

The company will present its newly CE-marked AI contouring solution at the annual congress of the European Society for Radiotherapy and Oncology in Stockholm.

The new CFO succeeds Henrik Bøggild, who left the company after three and a half years to pursue another professional opportunity.

The acquisition comes as Bayer seeks to reinforce its position in ophthalmology amid growing biosimilar competition facing Eylea, which it co-developed with Regeneron.

Photon Flash radiotherapy delivers radiation more than 100 times faster than conventional radiotherapy techniques, to reduce damage to surrounding healthy tissue while effectively targeting tumors.

The device collects saliva-free exhaled breath condensate from the distal lung while minimizing contamination from the mouth, upper airways, and environment, and it integrates into standard diagnostic workflows.